Skip to main content
. 2024 Nov 28;12(11):E1379–E1385. doi: 10.1055/a-2422-9363

Table 2 Characteristics of EUS-TA procedures.

Total ≤10 mm 10–20 mm >20 mm P value
EUS-TA, endoscopic ultrasound-guided tissue acquisition; FNA, fine-needle aspiration; IQR, interquartile range; MEN 1, multiple endocrine neoplasia type 1; MiNEN, mixed neuroendocrine/non-neuroendocrine neoplasm; NEC, neuroendocrine carcinoma; NET, neuroendocrine tumor.
Number of Cases 82 30 30 22
Needle type 0.38

  • FNA

 n (%) 3 (3.7) 2 (6.7) 0 (0.0) 1 (4.5)

  • FNB

 n (%) 79 (96.3) 28 (93.3) 30 (100) 21 (95.5)
Needle gauge 0.48

  • 22G

 n (%) 75 (91.5) 28 (93.3) 26 (86.7) 21 (95.5)

  • 25G

 n (%) 7 (8.5) 2 (6.7) 4 (13.3) 1 (4.5)
Number of punctures 0.07

  • 1 time

 n (%) 14 (17.1) 8 (26.7) 1 (3.3) 5 (22.7)

  • 2 times

 n (%) 55 (67.1) 20 (66.7) 23 (76.7) 12 (54.6)

  • 3 times

 n (%) 13 (15.9) 2 (6.7) 6 (20.0) 5 (22.7)
Puncture site 0.13

  • Transgastric

 n (%) 62 (75.6) 27 (90.0) 21 (70.0) 14 (63.6)

  • Transduodenal bulb

 n (%) 1 (1.2) 0 (0.0) 1 (3.3) 0 (0.0)

  • Transduodenal 2nd part

 n (%) 19 (23.2) 3 (10.0) 8 (26.7) 8 (36.4)
Complications of EUS-TA 0.45

  • Hemorrhage

 n (%) 1 (1.2) 0 (0.0) 1 (3.3) 0 (0.0)

  • Pancreatitis

 n (%) 2 (2.4) 1 (3.3) 1 (3.3) 0 (0.0)
EUS-TA diagnosis 0.16

  • NET G1

 n (%) 57 (69.5) 23 (76.7) 23 (76.7) 11 (50.0)

  • NET G2

 n (%) 8 (9.8) 3 (10.0) 3 (10.0) 2 (9.1)

  • NET G3

 n (%) 1 (1.2) 0 (0.0) 1 (3.3) 0 (0.0)

  • NET (grading undiagnosed)

 n (%) 5 (6.1) 3 (10.0) 0 (0.0) 2 (9.1)

  • NEC

 n (%) 5 (6.1) 0 (0.0) 2 (6.7) 3 (13.6)

  • MiNEN

 n (%) 2 (2.4) 0 (0.0) 0 (0.0) 2 (9.1)

  • No malignancy

 n (%) 4 (4.9) 1 (3.3) 1 (3.3) 2 (9.1)